logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kim Monkhorst

Netherlands Cancer Institute
H指数:41
被引数:7,483

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer cell-intrinsic rewiring of the colorectal cancer secretome

结直肠癌分泌组中癌细胞固有的重编程

iScience
IF4.1
2026-09-220
OAAI
Maartje Witsen; Theodoros Foskolos; Jelmer J. Dijkstra; Miguel Parra-Martinez; Joyce J.I. Catsman; Paula T. van Royen; Bob J. Ignacio; Onno Bleijerveld; Marije C. Kuiken; Alex van Vliet; Kim Monkhorst; Willemijn S.M. E. Theelen; Daniel Peeper; Joris van de Haar; Kimberly Bonger; Michiel Vermeulen; Emile E. Voest; Krijn K. Dijkstra
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer

25,946例非小细胞肺癌患者中NTRK融合的流行率及特征

Lung Cancer
IF4.4
2026-06-280
PRE
Teodora Radonic; Sepehr Rahmani-Khajouei; Urania Dafni; Albrecht Stenzinger; Martina Haberecker; Line Bille Madsen; Kim Monkhorst; Jacek Kowalski; Javier Hernandez-Losa; Keith M. Kerr; Ernst Jan M. Speel; Lukas Bubendorf; Leena Joseph; Atilio Navarro; Erik Thunnissen; Irene Sansano; Lisa M. Hillen; Wojciech Biernat; Miriam Christoffel; Lydia Tsamtsouri
Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers

作者更正：肿瘤全基因组测序在实体瘤中的临床实用性

Nature Medicine
IF50
2026-04-020
OAAI
Jeffrey van Putten; Petur Snaebjornsson; Linda J. W. Bosch; Roelof Koster; Paul Roepman; Joseph Usset; Mirjam C. Boelens; Tom van Wezel; Efraim H. Rosenberg; Serena Marchetti; Marieke Vollebergh; Doenja M. J. Lambregts; Lizet E. van der Kolk; Edwin Cuppen; Hilde H. Nienhuis; Kim Monkhorst
Real-world clinical utility of tumor whole-genome sequencing in solid cancers

实体癌中肿瘤全基因组测序的真实世界临床应用

Nature Medicine
IF50
2026-03-200
OAAI
Jeffrey van Putten; Petur Snaebjornsson; Linda J. W. Bosch; Roelof Koster; Paul Roepman; Joseph Usset; Mirjam C. Boelens; Tom van Wezel; Efraim H. Rosenberg; Serena Marchetti; Marieke Vollebergh; Doenja M. J. Lambregts; Lizet E. van der Kolk; Edwin Cuppen; Hilde H. Nienhuis; Kim Monkhorst
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study

帕博利珠单抗联合仑伐替尼作为恶性胸膜间皮瘤患者的二线治疗方案（PEMMELA研究）：一项单臂、II期研究的队列2

The Lancet Oncology
IF0
2025-11-240
PRE
Li-Anne H Douma; Vincent van der Noort; Ferry Lalezari; Jeltje F de Vries; Kim Monkhorst; Illaa Smesseim; Paul Baas; Bodien Schilder; Marrit Vermeulen; Jacobus A Burgers; Cornedine J de Gooijer
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study

确定识别奥希康替尼耐药性的最佳方法；OSIRIS研究中的奥希康替尼一线治疗队列

Lung Cancer
IF4.4
2025-09-280
PRE
J.W.T. van der Wel; S.M. Ernst; M. Jebbink; D. van den Broek; S.K. Badrising; L.C. Steinbusch; G. Ruiter; W.S.M.E. Theelen; B.A.M.H. van Veggel; J. Smit; A.M. Dingemans; M.S. Paats; H.J. Dubbink; S.M.S. Hashemi; T. Radonic; D. Cohen; A.J. van der Wekken; A. ter Elst; W. Timens; L.E. Hendriks; E.J.M. Speel; M.M.J. Disselhorst; A. Welling; F. van der Meer; L.J.W. Bosch; K. Monkhorst; M.C. Boelens; E.F. Smit; A.J. de Langen
ESMO Recommendations on clinical reporting of genomic test results for solid cancers

ESMO关于实体癌基因组检测结果临床报告的建议

ANNALS OF ONCOLOGY
IF65.4
2024-11-010
OAAI
van de Haar, J.; Roepman, P.; Andre, F.; Balmana, J.; Castro, E.; Chakravarty, D.; Curigliano, G.; Czarnecka, A. M.; Dienstmann, R.; Horak, P.; Marchio, C.; Italiano, A.; Monkhorst, K.; Pritchard, C. C.; Reardon, B.; Russnes, H. E. G.; Sirohi, B.; Sosinsky, A.; Spanic, T.; Turnbull, C.; Van Allen, E.; Westphalen, C. B.; Tamborero, D.; Mateo, J.
Predictive value of circulating tumor DNA (ctDNA) before and shortly after curative treatment in early stage non-small cell lung cancer (NSCLC), and exploration of (pre-)analytical factors

早期非小细胞肺癌（NSCLC）在根治性治疗前后循环肿瘤DNA（ctDNA）的预测价值，以及对（预）分析因素的探索

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
van den Heuvel, M.; Smith, C. G.; Schuurbiers, M.; Hartemink, K.; Rintoul, R.; Monkhorst, K.; Van Den Broek, D.; Rosenfeld, N.
Combined molecular analysis of circulating tumour DNA and tumour tissue to identify osimertinib resistance

结合循环肿瘤DNA和肿瘤组织的分子联合分析以识别奥希替尼耐药性

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
van der Wel, T.; Jebbink, M.; Badrising, S.; Steinbusch, L.; Ruiter, G.; Theelen, W. S. M. E.; Veggel, B. V.; Smit, J.; Hashemi, S.; Van Der Wekken, A. J.; Hendriks, L. E.; Paats, M. S.; Ernst, S.; Van Den Broek, D.; Bosch, L. J. W.; Monkhorst, K.; Smit, E. F.; Boelens, M. C.; De langen, A. J.
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study
NEURO-ONCOLOGY
IF13.4
2024-08-071
PRE
van der Wel, J. W. Tijmen; Boelens, Mirjam C.; Jebbink, Merel; Smulders, Sietske A.; Maas, Klaartje W.; Luitse, Merel J. A.; Compter, Annette; Boltjes, Robin P. B.; Sol, Nik; Monkhorst, Kim; van den Broek, Daan; Smit, Egbert F.; de Langen, Adrianus J.; Brandsma, Dieta
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics

基因咨询策略对基于基因组测序的肿瘤诊断的诊断率和工作量的影响

GENETICS IN MEDICINE
IF6.2
2024-02-011
OAAI
Koster, Roelof; Schipper, Luuk J.; Giesbertz, Noor A. A.; van Beek, Daphne; Mendeville, Matias; Samsom, Kris G.; Rosenberg, Efraim H.; Hogervorst, Frans B. L.; Roepman, Paul; Boelens, Mirjam C.; Bosch, Linda J. W.; van den Berg, Jose G.; Meijer, Gerrit A.; Voest, Emile E.; Cuppen, Edwin; Ruijs, Marielle W. G.; van Wezel, Tom; van der Kolk, Lizet; Monkhorst, Kim
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice

优化的全基因组测序工作流程，用于常规病理学实践中的肿瘤诊断

NATURE PROTOCOLS
IF16
2023-12-133
PRE
Samsom, Kris G.; Bosch, Linda J. W.; Schipper, Luuk J.; Schout, Daoin; Roepman, Paul; Boelens, Mirjam C.; Lalezari, Ferry; Klompenhouwer, Elisabeth G.; de Langen, Adrianus J.; Buffart, Tineke E.; van Linder, Berit M. H.; van Deventer, Kelly; van den Burg, Kay; Unmehopa, Unga; Rosenberg, Efraim H.; Koster, Roelof; Hogervorst, Frans B. L.; van den Berg, Jose G.; Riethorst, Immy; Schoenmaker, Lieke; van Beek, Daphne; de Bruijn, Ewart; van der Hoeven, Jacobus J. M.; van Snellenberg, Hans; van der Kolk, Lizet E.; Cuppen, Edwin; Voest, Emile E.; Meijer, Gerrit A.; Monkhorst, Kim
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer

阿法替尼联合西妥昔单抗治疗EGFR外显子20插入阳性非小细胞肺癌的2期临床试验

CANCER
IF5.1
2023-10-312
OAAI
van Veggel, Bianca A. M. H.; van der Wekken, Anthonie J.; Paats, Marthe S.; Hendriks, Lizza E. L.; Hashemi, Sayed M. S.; Daletzakis, Antonios; van den Broek, Daan; Bosch, Linda J. W.; Monkhorst, Kim; Smit, Egbert F.; de Langen, Adrianus J.

研究方向

暂未获取到该数据
E
Egbert F. Smit
H 指数:113论文数:1,213被引数:6.0万
D
Daan van den Broek
H 指数:28论文数:160被引数:2,774
M
Mirjam C. Boelens
H 指数:18论文数:74被引数:2,028
E
Edwin Cuppen
H 指数:102论文数:534被引数:4.9万
L
Linda J.W. Bosch
H 指数:23论文数:148被引数:1,997
P
Paul Roepman
H 指数:36论文数:225被引数:1.1万
G
Gerrit A. Meijer
H 指数:89论文数:1,107被引数:3.4万
E
Emile E. Voest
H 指数:92论文数:811被引数:3.8万
M
Michel M. van den Heuvel
H 指数:48论文数:409被引数:1.2万
M
M. Jebbink
H 指数:8论文数:23被引数:285